Archives: Speakers

Mary MacDonald is Director of Clinical Quality Assurance at Eisai, providing clinical quality leadership for outsourced development programs and enterprise‑level oversight of sponsor accountability and vendor governance under evolving GCP expectations. She brings more than 20 years of experience across clinical research and quality roles in large and mid‑size biopharma, including Takeda, Alexion (AstraZeneca Rare Disease), Radius Health, and bluebird bio. Mary works closely with clinical operations, procurement, and external partners to embed risk‑based quality practices and enable consistent execution across complex outsourcing models. She holds an MS in Clinical Research Organization and Management and is a Certified Quality Auditor and Registered QA Professional (GCP).

Sales director with 40 years of experience in business development, growth and GTM approach, Aldo Maria Camillo Caiani has a proven track record in matching Market and Customer needs with valuable business solutions addressing business processes optimization. He covered international roles as Managing Director, Senior Vice President, CEO, CBO (Chief Business Officer), CRO (Chief Revenue Officer) and Consultant in different Verticals working in SW (software) arena covering expertise on Manufacturing, Insurance, Banking, GDO, Food&Beverage, Financial Sector, Utilities and Energy.

Giuditta Carlotta Heinzl: Sensory and consumer researcher at Vinhood, she turns consumer data into actionable insight to support food innovation. She holds a PhD in Nutritional Sciences and has a strong scientific background in food science, she helps companies create products that truly connect with people’s needs, understanding consumer preferences and everyday choices that people make at the table.

Victoria Toms is Executive Director at the International Accrediting Organization for Clinical Research (IAOCR), driving global standards for quality across clinical research sites and professionals. She brings 19 years’ experience across all trial phases, multiple therapeutic areas, in both commercial and non-commercial settings, with expertise spanning site operations, trial management, quality assurance, and business development.

Working at the intersection of quality, strategy, and industry collaboration, Victoria focuses on strengthening trust, consistency, and performance across the research ecosystem. As expectations from organisations such as the ICH and global regulators continue to evolve, she positions quality as a strategic and commercial differentiator, that should shape site selection, enhance sponsor confidence, and ultimately improve patient outcomes. Through global accreditation programmes and the Global Best Practice Boards, she partners with sites, sponsors, and CROs to embed quality into culture and facilitate more predictable, high-performing research delivery.

Simon Torrance is a member of the Executive Working Group on Digital Transformation at the World Economic Forum. He works with leadership teams – across all parts of the insurance value chain – to create and implement effective strategies to deploy advanced forms of AI, focusing in particular on Agentic AI. He is also founder of Agentic AI innovation firm, AI Risk

Peter Haessig leads commercial strategy and execution at Diligent Pharma, the quality and compliance company specializing in end-to-end vendor lifecycle management for clinical trials. His remit spans sales, marketing, and partnerships across a client base of pharma and biotech sponsors and clinical service providers. An advocate of two-sided platforms, he believes network effects can streamline decades of redundant work in clinical trials. Before Diligent, Peter held sales and consulting roles across enterprise technology and SaaS.